دورية أكاديمية

A randomized phase II study comparing consolidation with a single dose of 90 Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

التفاصيل البيبلوغرافية
العنوان: A randomized phase II study comparing consolidation with a single dose of 90 Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
المؤلفون: López-Guillermo, Armando, Canales, Miguel Ángel, Dlouhy, Ivan, Mercadal, Santiago, Briones, Javier, Martín García-Sancho, Alejandro, Sancho, Juan Manuel, Moraleda, José María, Terol, María José, Salar, Antonio, Palomera, Luis, Gardella, Santiago, Jarque, Isidro, Ferrer, Secundino, Bargay, Joan, López, Andrés, Panizo, Carlos, Muntañola, Anna, Montalbán, Carlos, Conde, Eulogio, Hernández, Miguel T., Soler, Alfons, García Marco, José A., Deben, Guillermo, Marín, Julián, Tomás, José Francisco
المساهمون: SCHERING/BAYER
المصدر: Leukemia & Lymphoma ; volume 63, issue 1, page 93-100 ; ISSN 1042-8194 1029-2403
بيانات النشر: Informa UK Limited
سنة النشر: 2021
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1080/10428194.2021.1971216
الإتاحة: https://doi.org/10.1080/10428194.2021.1971216Test
رقم الانضمام: edsbas.4754B816
قاعدة البيانات: BASE